Liberum Biotech
Latest round
- Seed
Last raised
- Jul 2023
Total raised
- $1.8M
Investors
- 3
About Liberum Biotech
Liberum Biotech specializes in developing innovative solutions for protein synthesis, having been founded in 2020 in Toronto, Canada. The company was established by Aidan Tinafar, Alexander Klenov, and Ryan Fobel.Liberum Bio specializes in innovative cell-free protein expression reagents and hardware designed to facilitate enzyme and antibody discovery. Its core product offerings include high-yield cell-free reagents and proprietary formulations that enhance protein synthesis capabilities, alongside cartridges equipped with thin-film technology for effective scale-up and purification processes. The company provides protein synthesis as a service through its advanced cell-free systems, targeting businesses engaged in biotechnology, pharmaceuticals, and research institutions that require rapid prototyping and data generation for protein-related applications. By leveraging machine learning integrated with cell-free biology, Liberum Bio aims to deliver actionable insights more efficiently and cost-effectively than traditional methods.Liberum Bio generates revenue through its specialized products and services structured around B2B transactions. Clients engage with the company primarily through direct service agreements for protein synthesis, alongside the purchase of proprietary reagents and cartridges. These transactions typically involve customized contracts based on the specific needs of the client, allowing for tailored solutions that enhance research and development efforts. Pricing models are aligned with the complexity and volume of the requested services, reflecting the value of high-quality protein expression and discovery capabilities the company provides. The company plans to introduce new products that enhance its protein expression capabilities and expand its reach into new geographic markets. Specific targeted markets include Europe and parts of Asia, with plans to solidify these expansions within the next 12 to 18 months.
Who invested in Liberum Biotech
3 investors across 2 rounds
See all investors in Liberum Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Liberum Biotech
Who invested in Liberum Biotech?
Liberum Biotech has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Liberum Biotech raised?
Liberum Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Liberum Biotech last raise money?
Liberum Biotech's most recent round on record is a Seed, in Jul 2023.
What does Liberum Biotech do?
Liberum Biotech specializes in developing innovative solutions for protein synthesis, having been founded in 2020 in Toronto, Canada.
Where is Liberum Biotech headquartered?
Liberum Biotech is headquartered in Toronto, Canada.
Which VCs invest in companies like Liberum Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Liberum Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Liberum Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.